ANI Pharmaceuticals
ANIP
#4819
Rank
C$2.53 B
Marketcap
C$112.97
Share price
-1.17%
Change (1 day)
43.89%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.85 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is C$0.85 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.89 B136.36%
2023-12-31C$0.37 B-2.55%
2022-12-31C$0.38 B6.16%
2021-12-31C$0.36 B54.68%
2020-12-31C$0.23 B-2.41%
2019-12-31C$0.24 B-2.69%
2018-12-31C$0.24 B-1.6%
2017-12-31C$0.25 B56.26%
2016-12-31C$0.16 B3.04%
2015-12-31C$0.15 B27.26%
2014-12-31C$0.12 B
2013-12-31N/A-100%
2012-12-31C$7.83 M-55.54%
2011-12-31C$17.63 M-4.88%
2010-12-31C$18.53 M5.66%
2009-12-31C$17.54 M
2000-12-31C$0.74 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
C$7.49 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
C$7.08 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.58 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
C$84.06 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
C$0.88 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$3.62 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$12.47 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$44.23 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
C$12.35 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK